roxithromycin Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin is derived from erythromycin, containing the same 14-membered lactone ring. but with an N-oxime side chain attached to the ring.   Wikipedia

Chemistry

  • SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)\[C@H](C)[C@@H](O)[C@]1(C)O
  • InChIKey: RXZBMPWDPOLZGW-XMRMVWPWSA-N
  • Mol. Mass: 837.06
  • ALogP: 2.21
  • ChEMBL Molecule:
    roxithromycin  
More Chemistry

Pharmacology

Drug Pricing (per unit)

Australia

$0.1954 - $0.7412
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

(9e)-erythromycin 9-(o-((2-methoxyethoxy)methyl)oxime) | claramid | rotramin | roxacin | roxeptin | roxithromycin | roxithromycin a | roxithromycine | roxithromycinum | roxitromicina | ru-28965 | ru-965 | rulid | rulide

Organizations (7)

Research & Development (7)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (1)


 

Bacterial Infections

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Arthritis, Rheumatoid (Phase 4)

Bacterial Infections (Phase 4)

Infant, Premature (Phase 4)

Pacemaker, Artificial (Phase 4)

Quality of Life (Phase 3)

Respiratory Function Tests (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial Organizations: 7

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue